Prati
Andrew Cope
Andrew Cope
Professor of Rheumatology, King's College London
Potvrđena adresa e-pošte na kcl.ac.uk - Početna stranica
Naslov
Citirano
Citirano
Godina
Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation
MK Liszewski, M Kolev, G Le Friec, M Leung, PG Bertram, AF Fara, ...
Immunity 39 (6), 1143-1157, 2013
5462013
EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis
DM Gerlag, K Raza, LGM Van Baarsen, E Brouwer, CD Buckley, ...
Annals of the rheumatic diseases 71 (5), 638-641, 2012
5122012
Associations between immune-suppressive and stimulating drugs and novel COVID-19—a systematic review of current evidence
B Russell, C Moss, G George, A Santaolalla, A Cope, S Papa, ...
ecancermedicalscience 14, 2020
4902020
T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4+ T cells
G Arbore, EE West, R Spolski, AAB Robertson, A Klos, C Rheinheimer, ...
Science 352 (6292), aad1210, 2016
4862016
Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases
AP Cope, D Gibbons, FM Brennan, M Feldmann, D Aderka, M Doherty, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 1992
4311992
Treg cells suppress osteoclast formation: a new link between the immune system and bone
MM Zaiss, R Axmann, J Zwerina, K Polzer, E Gückel, A Skapenko, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2007
4042007
The central role of T cells in rheumatoid arthritis
AP Cope, H Schulze-Koops, M Aringer
Clinical and experimental rheumatology 25 (5), S4, 2007
3982007
Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling
AP Cope, RS Liblau, XD Yang, M Congia, C Laudanna, RD Schreiber, ...
The Journal of experimental medicine 185 (9), 1573-1584, 1997
3421997
The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells
S Jones, N Horwood, A Cope, F Dazzi
The Journal of Immunology 179 (5), 2824-2831, 2007
3292007
Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells
J Cardone, G Le Friec, P Vantourout, A Roberts, A Fuchs, I Jackson, ...
Nature immunology 11 (9), 862-871, 2010
3092010
Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in …
AP Cope, M Londei, NR Chu, SB Cohen, MJ Elliott, FM Brennan, ...
The Journal of clinical investigation 94 (2), 749-760, 1994
3001994
The Th1 life cycle: molecular control of IFN-γ to IL-10 switching
A Cope, G Le Friec, J Cardone, C Kemper
Trends in immunology 32 (6), 278-286, 2011
2862011
Why is PTPN22 a good candidate susceptibility gene for autoimmune disease?
GL Burn, L Svensson, C Sanchez-Blanco, M Saini, AP Cope
FEBS letters 585 (23), 3689-3698, 2011
2772011
Monocytes induce STAT3 activation in human mesenchymal stem cells to promote osteoblast formation
V Nicolaidou, MM Wong, AN Redpath, A Ersek, DF Baban, LM Williams, ...
PloS one 7 (7), e39871, 2012
2762012
A systematic review and meta-analysis of infection risk with small molecule JAK inhibitors in rheumatoid arthritis
K Bechman, S Subesinghe, S Norton, F Atzeni, M Galli, AP Cope, ...
Rheumatology 58 (10), 1755-1766, 2019
2562019
The role of tumour necrosis factor (TNF-α) in experimental autoimmune uveoretinitis (EAU)
AD Dick, JV Forrester, J Liversidge, AP Cope
Progress in retinal and eye research 23 (6), 617-637, 2004
2482004
Innate-like T cells straddle innate and adaptive immunity by altering antigen-receptor responsiveness
M Wencker, G Turchinovich, R Di Marco Barros, L Deban, A Jandke, ...
Nature immunology 15 (1), 80-87, 2014
2382014
Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 …
A Tyndall, UA Walker, A Cope, F Dazzi, C De Bari, W Fibbe, S Guiducci, ...
Arthritis research & therapy 9, 1-10, 2007
2322007
Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus
D Aderka, A Wysenbeek, H Engelmann, AP Cope, F Brennan, Y Molad, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 1993
2221993
Nitric oxide, chronic inflammation and autoimmunity
G Nagy, JM Clark, EI Buzás, CL Gorman, AP Cope
Immunology letters 111 (1), 1-5, 2007
2102007
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–20